You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of the study population

From: Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden

Characteristic (n = 122) Value (N (%))
Demographics  
 Age (years), mean ± SD 61.35 ± 11.72
 Male 82 (67.2)
 Black 11 (9.0)
Blood pressure (mmHg), mean ± SD  
 Systolic blood pressure 127.97 ± 23.01
(n = 118)
 Diastolic blood pressure 70.19 ± 13.29
(n = 118)
Medical history  
 Acute coronary syndrome on presentation 43 (35.2)
 Prior myocardial infarction 36 (29.5)
 Hypertension 95 (77.9)
 Diabetes 46 (37.7)
 Chronic dialysis 8 (6.6)
 Congestive heart failure 32 (26.2)
 Chronic obstructive lung disease 8 (6.6)
 Peripheral vascular disease 10 (8.2)
 Hyperlipidemia 91 (74.6)
 Current Smoker 12 (10.3)
(n = 116)
Medications  
 Aspirin 98 (80.3)
 Plavix 39 (32.0)
 Statins 87 (71.3)
 ACE/ARB 65 (53.3)
 β-blocker 86 (70.5)
Angiographic Findings  
 Number of diseased vessels, median [IQR] 1 [0.0, 2.0]
 Multi-vessel coronary disease 34 (27.9)
 Percent area stenosis (%), median [IQR] 4.96 [3.78, 6.37]
 Gensini Score 26.0 [19.5, 39.0]
Labs, mean ± SD  
 Ejection Fraction (%), median [IQR] 57.0 [45.0, 65.0]
(n = 81)
 Hemoglobin, (g/dL) 13.17 ± 1.85
(n = 119)
 White blood count (1000/mm3), median [IQR] 7.83 [6.22, 9.04]
(n = 120)
 LDL cholesterol (mg/dL) 86.76 ± 36.23
(n = 98)
 Serum creatinine (mg/dL), [median IQR] 1.05 [0.84, 1.30]
 Estimated glomerular filtration rate, (mL/min) 68.33 ± 30.41
  1. Baseline characteristics of the study population
  2. SD standard deviation, IQR inter-quartile range, Hg mercury, min minute. ACE/ARB angiotensin converting enzyme inhibitor/angiotensin receptor blocker